Related Content
Press Release
A federal grand jury returned a two-count indictment charging Ryan L. Peltan, 30, of Doylestown, and Derik W. Snell, 39, of Wooster, with possession with intent to distribute controlled substances, said Steven M. Dettelbach, U.S. Attorney for the Northern District of Ohio.
Count 1 of the indictment alleges that on October 26, 2015, Peltan and Snell possessed with the intent to distribute approximately 2,952 dose units of Adderall and approximately 90 dose units of Adderall patches, Schedule II controlled substances.
Count 2 of the indictment alleges that on the same date, Peltan and Snell possessed with the intent to distribute approximately 999 dose units of Alprazolam (Xanax), approximately 592 dose units of Conazepam, approximately 1,494 dose units of Lorazepam, and approximately 1,052 dose units of Tramadol, Schedule IV controlled substances.
If convicted, a defendant’s sentence will be determined by the Court after review of factors unique to this case, including the defendant’s prior criminal records, if any, the defendant’s role in the offense and the characteristics of the violation. In all cases, the sentence will not exceed the statutory maximum and in most cases it will be less than the maximum.
The investigation preceding the indictment was conducted by the Akron Police Department and the Drug Enforcement Administration. The case is being prosecuted by Assistant United States Attorney Linda H. Barr.
An indictment is only a charge and is not evidence of guilt. A defendant is entitled to a fair trial in which it will be the government’s burden to prove guilt beyond a reasonable doubt.